Skip to main content
. 2010 Nov 3;9:37. doi: 10.1186/1744-859X-9-37

Figure 3.

Figure 3

Effects of acute and subchronic treatment with etizolam and ethyl loflazepate on neuropsychological tests.

HHS Vulnerability Disclosure